Nazaflex Nasal Spray (Mometasone Furoate (Micronized), Azelastine Hydrochloride)

Adult use

1 spray in each nostril twice daily. Each spray contains 0.05mg of Mometasone Furoate and 0.14mg of Azelastine Hydrochloride. The total daily dose is 0.2mg of Mometasone Furoate and 0.56mg of Azelastine Hydrochloride.

Child use

Children aged 12 years and older: 1 spray in each nostril twice daily. Each spray contains 0.05mg of Mometasone Furoate and 0.14mg of Azelastine Hydrochloride. The total daily dose is 0.2mg of Mometasone Furoate.

This medicine should not be used in certain patients. For example, individuals allergic to this medicine or its components, those with untreated infections in the nasal mucosa, patients who have recently undergone nasal surgery or have nasal disorders, pregnant or nursing women, and children under 6 years old should not use this medication. Also, patients with tuberculosis, systemic infections, or shingles in the eyes should use this medicine with caution. Using this medicine may cause irritation of the nasal mucosa, leading to symptoms such as sneezing, itching, tingling, and nosebleeds. Additionally, discomfort such as a bitter taste or nausea may be experienced. If used for a long time, regular check-ups are necessary to monitor changes in the nasal mucosa, and if infections of the nasal or pharyngeal regions occur, discontinuation or treatment may be required. This medicine may cause drowsiness, so caution should be taken when driving or operating hazardous machinery, and it is advisable not to use it simultaneously with other antihistamines. In particular, there is a risk of infection with chickenpox or measles while using this medicine, so vaccination status should be checked and immediate consultation with a doctor is advised if infection is suspected. In children, it is advised that those under 12 years old should not use this medicine, and regular monitoring of growth is recommended due to the potential for growth delay during use. In case of overdose, symptoms such as agitation, tremors, or seizures may arise, necessitating caution, and it is recommended to observe without special treatment. This medicine is for nasal administration only; shake the container well before use and perform a test spray. Care should be taken to avoid direct spraying in the eyes or on the septum, and communal use should be avoided to prevent contamination. Store this medication in a tightly closed container to protect it from external air or moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. This will help safely maintain the effectiveness of the medicine.

Serious side effects

Allergic reactions (anaphylaxis), angioedema (angioneurotic edema), septal perforation, increased intraocular pressure, bronchospasm, dyspnea, severe bacterial infections (fever, facial pain, facial swelling), blurred vision, acute adrenal insufficiency, adrenal insufficiency, missed abortion.

Mild side effects

• Bitter taste
• headache
• drowsiness
• nasal burning
• pharyngitis
• dry mouth
• paroxysmal sneezing
• nausea
• rhinitis
• fatigue

This medicine should be stored in a tightly closed container to protect it from external air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. This will help ensure the safety of the medication's effectiveness.

Appearance

A white or nearly white opaque suspension dispensed in a certain amount from an opaque plastic container in the form of a nasal spray.

Package unit

18mL/bottle